Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial update examining the efficacy and biomarker explanation of IBI-322 combined with lenvatinib in extensive-stage small cell lung…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers [Phase 1, Phase 2]
NCI-sponsored Phase 1/2 trial evaluating PLX038 (PEGylated SN38) in combination with Rucaparib in solid tumors and small cell cancers, with …
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Durvalumab(MEDI4736) and AZD6738 Combination Therapy in Relapsed Small Cell Lung Cancer Subjects [Phase 2]
Phase 2 trial evaluating the combination of durvalumab (MEDI4736) and AZD6738 in relapsed small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer Subjects [Phase 2]
Phase 2 clinical trial update evaluating olaparib and bevacizumab in relapsed small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma [Phase 2]
Phase 2 trial evaluating the combination of rucaparib and nivolumab in small cell lung cancer has completed and results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating guadecitabine in combination with carboplatin for extensive-stage small cell lung cancer has completed with posted …
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Pembrolizumab in Untreated Extensive SCLC [Phase 2]
Phase 2 trial update of pembrolizumab for untreated extensive-stage small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer. [Phase 1, Phase 2]
A clinical trial evaluating the safety, tolerability, and efficacy of PM01183 combined with atezolizumab in advanced small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2023-10-30Clinical Trial Update: Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Tumor Treating Fields (TTFields) therapy for brain metastases in small cell lung cancer; the study was terminated w…
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer [Phase 3]
Phase 3 study of irinotecan liposome injection (ONIVYDE) in small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
A Phase I/II study evaluating atezolizumab in combination with olaparib in patients with advanced solid tumors, including ovarian, breast, s…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 trial update on HTMC0435 combined with Temozolomide for recurrent extensive-stage small cell lung cancer, with current status no…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC [Phase 2]
Phase 2 trial evaluating tislelizumab with sitravatinib as maintenance therapy for extensive-stage small cell lung cancer (ES-SCLC).
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer [Phase 2]
Phase 2 trial of ADI-PEG 20 in combination with gemcitabine and docetaxel for soft tissue sarcoma, osteosarcoma, Ewing's sarcoma, and small …
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer [Phase 1, Phase 2]
A clinical trial updating safety and activity of Nivatrotamab in relapsed/recurrent metastatic small-cell lung cancer has been terminated wi…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating MK-0646 in combination with etoposide and cisplatin for extensive-stage small cell lung cancer has com…
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer [Phase 2]
Phase 2 trial evaluating nab-paclitaxel with gemcitabine for relapsed small cell lung cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2023-07-14Clinical Trial Update: SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC) [Phase 1, Phase 2]
A Phase 1/2 trial evaluating SC0245 in combination with Irinotecan for relapsed extensive-stage small cell lung cancer is registered, with u…
-
CLINICAL_TRIALS trial_result · 2023-06-23Clinical Trial Update: Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated cisplatin/carboplatin and etoposide with or without nivolumab in patients with extensive-stage small cell lung can…
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide [Phase 3]
A Phase 3 clinical trial update evaluating radiation therapy regimens in limited-stage small cell lung cancer patients treated with cisplati…
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating vorolanib in combination with atezolizumab as maintenance therapy for extensive-stage small cell lung cancer has …
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Immunotherapy in Combination With Chemotherapy in Small-cell Lung Cancer [Phase 2]
Phase 2 trial investigating immunotherapy combined with chemotherapy in small-cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors [Phase 1]
Phase 1 study evaluating the safety of the CHK1 inhibitor VX-970 (M6620) in combination with whole-brain radiation therapy for brain metasta…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung Cancer [Phase 2]
Phase 2 pilot study evaluating tislelizumab (PD-1 inhibitor) plus chemotherapy as neoadjuvant therapy for limited-stage small-cell lung canc…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating navitoclax with vistusertib in relapsed small cell lung cancer and other solid tumors; the study is terminated wi…